Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Lymphoma
			Radiation Toxicity
2		Additional conditions recognized in this trial
			Hodgkin Disease
			Lymphoma, Non-Hodgkin
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			daclizumab
			pentetic acid calcium
5		Additional drug interventions recognized in this trial
			Pentetic Acid
6		More general drug interventions related to this trial
			Antidotes
			Chelating Agents
			Immunologic Factors
			Immunosuppressive Agents
			Iron Chelating Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Protective Agents
7		Sponsors listed in this trial
			National Cancer Institute (NCI)